hypertension - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased Peripheral Resistance - Hypertension often results from the narrowing of blood vessels, primarily due to chronic constriction or damage to the arterial walls. This narrowing increases the resistance against blood flow, requiring the heart to pump harder, raising blood pressure.

• Secondary mechanism: Renin-Angiotensin-Aldosterone System (RAAS) Overactivity - Overactivation of the RAAS leads to increased angiotensin II levels, a potent vasoconstrictor, and stimulates aldosterone release, promoting sodium and water retention. This elevates blood volume and pressure.

• Key complication: Endothelial Dysfunction - Persistent high blood pressure can damage the endothelial lining of blood vessels, promoting atherosclerosis and increasing the risk of cardiovascular events such as heart attack and stroke.

Patient Profile

Demographics:

57-year-old male, construction worker

History:

• Key past medical history: Hypertension diagnosed 5 years ago, family history of cardiovascular disease

• Current medications: Lisinopril 20 mg daily, Amlodipine 5 mg daily

• Allergies: Penicillin (rash)

Current Presentation:

• Chief complaint: Increasing fatigue and occasional headaches

• Key symptoms: Shortness of breath on exertion, mild chest discomfort, occasional dizziness

• Vital signs: Blood pressure 160/100 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F

Section 1

Initial Assessment Findings:

Upon further evaluation, the patient's initial assessment reveals additional concerning symptoms and physical examination findings that warrant further investigation. The patient reports experiencing increased frequency of headaches, now occurring almost daily and accompanied by a sensation of pressure behind the eyes. On physical examination, there is mild jugular venous distention, suggesting potential fluid overload or cardiac involvement. Auscultation of the heart reveals a noticeable S4 gallop, indicative of potential left ventricular hypertrophy secondary to prolonged hypertension. Breath sounds are clear, but the patient exhibits mild peripheral edema in the lower extremities, which could be suggestive of early heart failure.

Laboratory tests are ordered to provide further insight into the patient's condition. The basic metabolic panel shows a mild elevation in serum creatinine at 1.5 mg/dL, indicating possible renal impairment, which can occur due to prolonged hypertension. Electrolyte levels are within normal ranges, but the lipid profile reveals elevated LDL cholesterol at 155 mg/dL and low HDL cholesterol at 38 mg/dL, highlighting an increased risk for atherosclerotic cardiovascular disease. An EKG performed in the clinic shows signs of left ventricular hypertrophy, with significant QRS voltage and strain pattern changes.

The clinical picture suggests that the patient's hypertension is not well-controlled, leading to the development of target organ damage, particularly affecting the heart and kidneys. These findings necessitate a re-evaluation of the current antihypertensive regimen and consideration of additional therapeutic interventions to address the underlying pathophysiological mechanisms. The primary focus should be on optimizing blood pressure control and mitigating the risk factors for cardiovascular events, necessitating further diagnostic imaging and potentially the involvement of a cardiologist or nephrologist for specialized management.

Section 2

New Diagnostic Results:

Following the initial assessment, further diagnostic tests were performed to gain a more comprehensive understanding of the patient's condition. An echocardiogram was conducted, revealing significant left ventricular hypertrophy with a preserved ejection fraction of 55%, suggesting that while the heart muscle is thickened, systolic function remains intact. However, the diastolic dysfunction was noted, indicating impaired relaxation of the left ventricle, which can contribute to symptoms of heart failure despite normal ejection fraction.

Additionally, a renal ultrasound was ordered to assess for any structural abnormalities that might contribute to the patient's renal impairment. The ultrasound findings showed bilateral small kidneys with increased echogenicity, consistent with chronic hypertensive nephrosclerosis. This suggests long-standing hypertension has led to irreversible kidney damage, reinforcing the need for aggressive management to prevent further deterioration.

With these new diagnostic results, the clinical team recognizes the critical importance of optimizing the patient's blood pressure and addressing the underlying cardiac and renal pathologies. The findings underscore the need for a multidisciplinary approach, with potential adjustments to the antihypertensive regimen, possibly including the addition of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker to provide renal protection and further improve cardiovascular outcomes. Consideration for referral to a nephrologist for collaborative care and possibly a cardiologist for detailed cardiac evaluation and management is warranted.

Section 3

Change in Patient Status:

After the new diagnostic results were discussed, the clinical team initiated adjustments to the patient's treatment plan. The patient's antihypertensive regimen was intensified with the addition of an angiotensin-converting enzyme (ACE) inhibitor, aiming to provide renal protection and improve cardiac function. Over the following weeks, the patient was closely monitored for changes in blood pressure and renal function. Initially, there was a notable improvement; blood pressure readings averaged 132/78 mmHg, and the patient's symptoms of fatigue and breathlessness seemed to diminish. However, during a routine follow-up, the patient reported experiencing increased episodes of dizziness and occasional palpitations.

Subsequent evaluation revealed a concerning change in the patient's vital signs and lab values. Blood pressure had dropped significantly to 110/68 mmHg, indicating possible overcorrection. The patient’s heart rate was noted to be irregular, with occasional premature ventricular contractions on telemetry. Laboratory tests showed a slight increase in serum creatinine from 1.5 mg/dL to 1.8 mg/dL, suggesting a potential strain on renal function. These findings prompted the clinical team to reassess the current medication regimen and consider the risk of potential complications such as orthostatic hypotension and worsening renal impairment.

Given the new developments, the clinical reasoning process focused on balancing the need for adequate blood pressure control with the prevention of adverse effects. The team decided to adjust the ACE inhibitor dosage and recommended lifestyle modifications to further support blood pressure management. Additionally, referral to a cardiologist was prioritized to address the cardiac irregularities and prevent further complications. The patient's journey highlights the complexity of managing hypertension with existing comorbidities, underscoring the importance of continuous monitoring and interdisciplinary collaboration in optimizing patient outcomes.

Section 4

As the clinical team continued to monitor the patient, further changes in the patient's status were observed. The patient presented to the clinic with complaints of persistent dizziness, particularly upon standing, and noted a decrease in urinary output over the past few days. A focused physical examination revealed orthostatic hypotension, with blood pressure readings of 98/60 mmHg when standing, compared to 110/68 mmHg when seated. This drop in blood pressure upon standing confirmed the suspicion of orthostatic hypotension, likely exacerbated by the recent adjustment in antihypertensive therapy.

Laboratory investigations were repeated to assess the extent of renal impairment. Serum creatinine levels had increased further to 2.1 mg/dL, raising concerns about acute kidney injury. Additionally, the patient's electrolytes showed a mild hyperkalemia, with a potassium level of 5.6 mEq/L, which could be attributed to the use of the ACE inhibitor. This finding necessitated immediate intervention to avoid potential cardiac complications. The patient's ECG still showed occasional premature ventricular contractions, though no significant arrhythmias were present at this time.

In response to these developments, the clinical team opted to reduce the dose of the ACE inhibitor to mitigate renal strain and address the electrolyte imbalance. The patient was advised to increase fluid intake to aid in managing orthostatic symptoms and was instructed to monitor blood pressure regularly. A potassium-restricted diet was also recommended to manage hyperkalemia. The team emphasized the need for close follow-up and arranged for more frequent laboratory assessments to closely monitor renal function and electrolyte levels. This approach aimed to stabilize the patient's condition while minimizing the risk of further complications, highlighting the delicate balance required in managing patients with complex hypertensive conditions.

Section 5

As the clinical team continued to closely monitor the patient, they observed new developments that necessitated further intervention. Despite the initial adjustments in the patient's medication regimen, the patient returned to the clinic with complaints of increasing fatigue and muscle weakness. Upon examination, the patient's blood pressure remained lower than usual, with readings of 94/58 mmHg while standing. The orthostatic hypotension persisted, and further assessment revealed that the patient's heart rate had increased to 102 beats per minute, indicating a compensatory response to the low blood pressure.

New laboratory results showed that the patient's serum creatinine levels remained elevated at 2.2 mg/dL, with no significant improvement in renal function. The potassium level, however, had decreased slightly to 5.4 mEq/L, suggesting a partial response to dietary modifications and medication adjustments. Despite these changes, the patient's symptoms indicated that the current management strategy might need further refinement. Additionally, a repeat ECG revealed more frequent premature ventricular contractions, raising concerns about the stability of the patient's cardiac rhythm.

In response to these findings, the clinical team decided to further adjust the patient's medication by introducing a low-dose diuretic to assist in managing fluid balance and reducing cardiac workload. This decision was made cautiously, considering the patient's renal function. The patient was also educated on recognizing signs of worsening electrolyte imbalances and instructed to report any new symptoms immediately. The team scheduled a follow-up appointment for additional laboratory tests and a comprehensive review of the patient's cardiovascular status, aiming to prevent further complications and optimize the management of the patient's hypertension and associated conditions.